Sorafenib induces ferroptosis by promoting TRIM54-mediated FSP1 ubiquitination and degradation in hepatocellular carcinoma
Open Access
- 11 September 2023
- journal article
- research article
- Published by Wolters Kluwer Health in Hepatology Communications
- Vol. 7 (10)
Abstract
Background: Ferroptosis is a unique form of regulated cell death that provided a new opportunity for cancer therapy. Ferroptosis suppressor protein 1 (FSP1) is a key regulator in the NAD(P)H/FSP1/CoQ10 antioxidant system, which sever as an oxide redox enzyme to scavenge harmful lipid hydroperoxides and escape from ferroptosis in cells. This study aimed to investigate the role of FSP1 on sorafenib-induced ferroptosis and disclosed the underlying mechanisms. Methods: Cell viability, malondialdehyde (MDA), glutathione (GSH), and lipid reactive oxygen species levels were assessed using indicated assay kits. The levels of FSP1 and glutathione peroxidase 4 (GPX4) in the patients with HCC were analyzed based on the database. Western blot and quantitative real-time PCR were performed to detect the protein and mRNA expression. Co-immunoprecipitation was applied to detect the interaction between proteins. Tumor xenograft experiments were used to evaluate whether overexpression of FSP1-inhibited sorafenib-induced ferroptosis in vivo. Results: We verified that sorafenib-induced ferroptosis in HCC. Furthermore, we found that sorafenib decreased the protein level of FSP1, and knockdown FSP1 rendered HCC cells susceptible to sorafenib-induced ferroptosis. Co-immunoprecipitation and ubiquitination assays showed that sorafenib accelerated the TRIM54-mediated FSP1 ubiquitination and degradation. Sorafenib-induced ferroptosis was abrogated by TRIM54 suppression. Mechanically, sorafenib-promoted TRIM54 ubiquitinated and degraded FSP1 by means of the ERK pathway. Moreover, FSP1 enhanced tumor development and decreased HCC cellular susceptibility to sorafenib in vivo. Conclusions: Sorafenib facilitated the TRIM54-mediated FSP1 ubiquitination through the ERK pathway, thereby inducing ferroptosis in HCC cells.Keywords
This publication has 49 references indexed in Scilit:
- TRIM Family Proteins: Roles in Autophagy, Immunity, and CarcinogenesisTrends in Biochemical Sciences, 2017
- ARF6, induced by mutant Kras, promotes proliferation and Warburg effect in pancreatic cancerCancer Letters, 2017
- Sorafenib induces ferroptosis in human cancer cell lines originating from different solid tumors.2014
- Pharmacological inhibition of cystine–glutamate exchange induces endoplasmic reticulum stress and ferroptosiseLife, 2014
- Iron‐dependent cell death of hepatocellular carcinoma cells exposed to sorafenibInternational Journal of Cancer, 2013
- Ferroptosis: An Iron-Dependent Form of Nonapoptotic Cell DeathCell, 2012
- Targeted therapy for hepatocellular carcinoma: novel agents on the horizonOncotarget, 2012
- Sorafenib for the treatment of unresectable hepatocellular carcinomaBiologics: Targets and Therapy, 2008
- Myosin accumulation and striated muscle myopathy result from the loss of muscle RING finger 1 and 3Journal of Clinical Investigation, 2007
- AMID, an Apoptosis-inducing Factor-homologous Mitochondrion-associated Protein, Induces Caspase-independent ApoptosisJournal of Biological Chemistry, 2002